The corporate-backed health management service raised the cash from Perceptive Advisors and has used $30m to buy musculoskeletal-focused Physera.

Life sciences investment firm Perceptive Advisors has provided an amount reported by CNBC to be $57m in funding for Omada Health, a US-headquartered illness management platform developer backed by several corporates. Omada has used $30m of the cash to fund the acquisition of Physera, the US-based creator of a musculoskeletal injury management app that had…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.